Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML

Affiliations

• ¹ Division of Hematology/Oncology, University of Virginia, Charlottesville, VA.
• ² Division of Hematology, James Cancer Center, The Ohio State University, Columbus, OH.
• ³ Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Sorbonne Université, INSERM UMRS 938, Paris, France.
• ⁴ Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN.
• ⁵ Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada.
• ⁶ Division of Blood and Marrow Transplantation, Stanford University, Palo Alto, CA.
• ⁷ Division of Hematology and Oncology, George Washington University Cancer Center, Washington, DC.
• ⁸ Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
• ⁹ National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
• ¹⁰ Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL; and.
• ¹¹ National Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.